Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Phase 2 Study to Evaluate the Immunogenicity and Safety of a Prophylactic Vaccination of Health Care Providers by Administration of a Heterologous Vaccine Regimen Against Ebola in the Democratic Republic of the Congo

NCT04186000 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT04186000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04186000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Phase 2 Study to Evaluate the Immunogenicity and Safety of a Prophylactic Vaccination of Health Care Providers by Administration of a Heterologous Vaccine Regimen Against Ebola in the Democratic Republic of the Congo
Lead sponsor
Universiteit Antwerpen
Phase
Phase 2
Overall status
Completed
Start date
December 18, 2019
Completion date
October 12, 2022
Enrollment
699 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ebola virus disease